doxylamine + pyridoxine + folic acid

**Goodmorn** is a combination pharmaceutical product marketed by **Dwd Pharmaceuticals** in India, primarily indicated for the management of **nausea and vomiting of pregnancy (NVP)**, commonly known as morning sickness. The formulation typically consists of three active ingredients: **doxylamine succinate**, a first-generation antihistamine that acts as an H1 receptor antagonist with antiemetic properties; **pyridoxine hydrochloride** (Vitamin B6), which is involved in amino acid metabolism and has been shown to reduce nausea; and **folic acid** (Vitamin B9), which is essential for fetal neural tube development. This combination provides a multi-modal approach to managing pregnancy-related nausea while ensuring essential vitamin supplementation during the first trimester.

Brand names

Goodmorn

Other names

doxylamine succinate + pyridoxine hydrochloride + folic acid